Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

A study reveals chronic sinusitis may increase rheumatic disease risk by 40%, especially 5-10 years before symptoms. Sinusitis inflames nasal passages, obstructs mucus flow, and hampers breathing. The ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

Chronic sinusitis is a condition where inflammation and infection in your sinuses persists for extended periods of time without relief. Your sinuses work as a filter, creating mucus that drains ...

Sinusitis is a condition that occurs when sinuses become inflamed due to infections Read this article to know what might be ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

It is estimated that about 107 million people in China suffer from chronic sinusitis, about 1/3 of ... Nucala for chronic obstructive pulmonary disease or smoker's lungs. The trial met its primary ...

Acute sinusitis lasts a short time, while chronic sinusitis persists for more than 12 weeks. Common causes include respiratory infections, nasal polyps, or a deviated septum. In addition to ...

If an oroantral communication is suspected, prompt surgical management is recommended to reduce the likelihood of causing chronic sinus disease.

Pilonidal disease is an acute or chronic infection in the subcutaneous ... This method is also problematic in patients with a pilonidal sinus larger than 4–5 cm and in those who have undergone ...